Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV393
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This non-competitive delivery order was issued on January 9, 2026, with an ultimate completion date of February 2, 2026. Vyndamax (tafamidis) is a stabilizer of transthyretin used in the treatment of transthyretin amyloidosis, a rare genetic disorder affecting protein structure and function. The award represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal healthcare supply chain. The company, a subsidiary of parent entity Cencora, Inc., holds extensive federal contracting experience supplying specialty medications, generic drugs, vaccines, and medical devices to military treatment facilities and the Defense Health Agency. The firm-fixed-price delivery order will be performed at the company's Conshohocken location, leveraging its established logistics and distribution capabilities to support the Department of Defense's medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FV393?
SPE2DR26FV393 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FV393 worth?
The government has obligated $14,593 on SPE2DR26FV393.
Is contract SPE2DR26FV393 an order under another contract?
Yes. SPE2DR26FV393 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV393 competed?
The extent of competition for SPE2DR26FV393 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award